In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.

To date there is compelling in vitro and in vivo evidence for epidermal H2O2 accumulation in vitiligo. This paper reviews the literature and presents new data on oxidative stress in the epidermal compartment of this disorder. Elevated H2O2 levels can be demonstrated in vivo in patients compared with healthy controls by utilizing Fourier-Transform Raman spectroscopy. H2O2 accumulation is associated with low epidermal catalase levels. So far, four potential sources for epidermal H2O2 generation in vitiligo have been identified: (i) perturbed (6R)-L-erythro 5,6,7,8 tetrahydrobiopterin (6BH4) de novo synthesis/recycling/regulation; (ii) impaired catecholamine synthesis with increased monoamine oxidase A activities; (iii) low glutathione peroxidase activities; and (iv) "oxygen burst" via NADPH oxidase from a cellular infiltrate. H2O2 overproduction can cause inactivation of catalase as well as vacuolation in epidermal melanocytes and keratinocytes. Vacuolation was also observed in vitro in melanocytes established from lesional and nonlesional epidermis of patients (n = 10) but was reversible upon addition of catalase. H2O2 can directly oxidize 6BH4 to 6-biopterin, which is cytotoxic to melanocytes in vitro. Therefore, we substituted the impaired catalase with a "pseudocatalase". Pseudocatalase is a bis-manganese III-EDTA-(HCO3-)2 complex activated by UVB or natural sun. This complex has been used in a pilot study on 33 patients, showing remarkable repigmentation even in long lasting disease. Currently this approach is under worldwide clinical investigation in an open trial. In conclusion, there are several lines of evidence that the entire epidermis of patients with vitiligo is involved in the disease process and that correction of the epidermal redox status is mandatory for repigmentation.

[1]  H. Taguchi,et al.  Peroxidase catalysed aerobic degradation of 5,6,7,8-tetrahydrobiopterin at physiological pH. , 1983, European journal of biochemistry.

[2]  T. Iguchi,et al.  Postnatal development of uterine abnormalities in mice exposed to DES in utero. , 1987, Biology of the neonate.

[3]  J. Wood,et al.  Low catalase levels in the epidermis of patients with vitiligo. , 1991, The Journal of investigative dermatology.

[4]  S. Kaufman,et al.  8 – PTERIN-REQUIRING AROMATIC AMINO ACID HYDROXYLASES , 1974 .

[5]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[6]  C. Nathan,et al.  Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. , 1989, The Journal of biological chemistry.

[7]  I. Buño,et al.  Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. , 1991, The Journal of investigative dermatology.

[8]  J. Bystryn,et al.  Serum antibodies in vitiligo patients. , 1989, Clinics in dermatology.

[9]  E. Medrano,et al.  Successful culture of adult human melanocytes obtained from normal and vitiligo donors. , 1990, The Journal of investigative dermatology.

[10]  C. Arrowsmith,et al.  Solution structure of a conserved C‐terminal domain of p73 with structural homology to the SAM domain , 1999, The EMBO journal.

[11]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[12]  J. Bhawan,et al.  Keratinocyte damage in vitiligo , 1983, Journal of cutaneous pathology.

[13]  J. Ortonne,et al.  Vitiligo: where do we stand? , 1993, Pigment cell research.

[14]  A. Yang,et al.  Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. , 2000, Cancer research.

[15]  J. McLachlan,et al.  Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. , 1980, Cancer research.

[16]  J. Wood,et al.  EF-hands calcium binding regulates the thioredoxin reductase/thioredoxin electron transfer in human keratinocytes , 1989 .

[17]  W. Westerhof,et al.  Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. , 1993, The Journal of investigative dermatology.

[18]  J. Sawatzki,et al.  In vivo evidence for compromised phenylalanine metabolism in vitiligo. , 1998, Biochemical and biophysical research communications.

[19]  N. Ueno,et al.  Regulation of epidermal induction by BMP2 and BMP7 signaling. , 1997, Developmental biology.

[20]  A. Kuroiwa,et al.  In vivo analysis using variants of zebrafish BMPR-IA: range of action and involvement of BMP in ectoderm patterning. , 1999, Development.

[21]  J. Bystryn,et al.  Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. , 1988, The Journal of investigative dermatology.

[22]  H. Green,et al.  The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein , 1977, Cell.

[23]  J U Bowie,et al.  p53 Family members p63 and p73 are SAM domain‐containing proteins , 1999, Protein science : a publication of the Protein Society.

[24]  M. Pittelkow,et al.  Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. , 1986, The Journal of investigative dermatology.

[25]  J. Ortonne,et al.  Vitiligo and depigmentation , 1992 .

[26]  E. Fuchs,et al.  Programming gene expression in developing epidermis. , 1994, Development.

[27]  P. Wilson,et al.  Induction of epidermis and inhibition of neural fate by Bmp-4 , 1995, Nature.

[28]  A. Yang,et al.  p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.

[29]  M. Pittelkow,et al.  Serum‐free culture of normal human melanocytes: Growth kinetics and growth factor requirements , 1989, Journal of cellular physiology.

[30]  T. Bonner,et al.  Purification and Cloning of the GTP Cyclohydrolase I Feedback Regulatory Protein, GFRP* , 1996, The Journal of Biological Chemistry.

[31]  S. Kaufman,et al.  "7-tetrahydrobiopterin," a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  X. F. Wang,et al.  Smad5 induces ventral fates in Xenopus embryo. , 1997, Developmental biology.

[33]  S. Passi,et al.  Catecholamines and vitiligo. , 1992, Pigment cell research.

[34]  T. Kalland,et al.  Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. , 1981, Cancer research.

[35]  Peer Bork,et al.  SAM as a protein interaction domain involved in developmental regulation , 1997, Protein science : a publication of the Protein Society.

[36]  M. Pittelkow,et al.  Cytotoxicity of 6-biopterin to human melanocytes. , 1994, Biochemical and biophysical research communications.

[37]  C. Guillouf,et al.  Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.

[38]  F. McKeon,et al.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.

[39]  M. Pittelkow,et al.  Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. , 1994, Science.

[40]  C. Grund,et al.  Formation of cytoskeletal elements during mouse embryogenesis. II. Epithelial differentiation and intermediate-sized filaments in early postimplantation embryos. , 1981, Differentiation; research in biological diversity.

[41]  W. Westerhof,et al.  Review of the etiopathomechanism of vitiligo: A convergence theory , 1993, Experimental dermatology.

[42]  M. L. Gardner,et al.  A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. , 1995, Biochemical and biophysical research communications.

[43]  E. Dellambra,et al.  Downregulation of 14-3-3σ Prevents Clonal Evolution and Leads to Immortalization of Primary Human Keratinocytes , 2000, The Journal of cell biology.

[44]  J. Bystryn,et al.  Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. , 1991, The Journal of investigative dermatology.

[45]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[46]  J. Wood,et al.  Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. , 1995, Dermatology.

[47]  B. Blumberg,et al.  Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction. , 1995, Genes & development.

[48]  E. Medrano,et al.  Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. , 1991, The Journal of investigative dermatology.

[49]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[50]  S. Passi,et al.  Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. , 1997, The Journal of investigative dermatology.

[51]  P. Kenemans,et al.  Expression of Cytokeratins in Early Neoplastic Epithelial Lesions of the Uterine Cervix , 1985, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[52]  M. Pittelkow,et al.  Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. , 1994, Biochimica et biophysica acta.

[53]  R. Leube,et al.  Squamous cell metaplasia in the human lung: molecular characteristics of epithelial stratification , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[54]  T. Sun,et al.  Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.